06May 2024
Efficacy of Extrafine Beclomethasone/Formoterol in Adult Asthma Control: Insights from the CONTROL Trial

Efficacy of Extrafine Beclomethasone/Formoterol in Adult Asthma Control: Insights from the CONTROL Trial

A recent study evaluated the effectiveness of extrafine beclomethasone/formoterol combination (BDP/F pMDI HFA) in asthma management. Conducted on 2179 adults over two months, the study found improved lung function, symptom control, and patient compliance. FEV1% increased, ACQ-7 scores decreased, and patient compliance improved significantly. Additionally, the use of BDP/F pMDI HFA as both maintenance and reliever therapy resulted in fewer as-needed doses. Patients expressed satisfaction with the inhaler's convenience and preferred it over dry powder inhalers. These findings suggest BDP/F pMDI HFA enhances asthma control and treatment adherence.

  • #pulmonology

Like

Save

Share